Niki BioSolutions, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
Niki BioSolutions, Inc. (NIKI) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 403.82 thousand shares for the 6-month period ending 2023-06-30, per its 6-K filed 2023-12-22.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2023-12-22
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month as first filed |
|---|---|---|---|
| 2023-06-30 | 403.82K shares 6-K · filed 2023-12-22 | ||
| 2022-12-31 | 153.15K shares 20-F · filed 2023-04-28 | ||
| 2022-06-30 | 153.13K shares 6-K · filed 2023-12-22 | ||
| 2021-12-31 | 75.23K shares 20-F · filed 2023-04-28 | 752.18K shares 20-F · filed 2022-04-29 | |
| 2020-12-31 | 71.34K shares 20-F · filed 2023-04-28 | 713.04K shares 20-F · filed 2022-04-29 | |
| 2019-12-31 | 218.22K shares 20-F/A · filed 2023-01-17 |